These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 2417352

  • 1. Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisol.
    Aillaud MF, Juhan-Vague I, Alessi MC, Marecal M, Vinson MF, Arnaud C, Vague P, Collen D.
    Thromb Haemost; 1985 Aug 30; 54(2):466-8. PubMed ID: 2417352
    [Abstract] [Full Text] [Related]

  • 2. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
    Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C.
    Diabete Metab; 1987 Jul 30; 13(3 Pt 2):331-6. PubMed ID: 3115843
    [Abstract] [Full Text] [Related]

  • 3. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor in man.
    Brommer EJ, Derkx FH, Schalekamp MA, Dooijewaard G, vd Klaauw MM.
    Thromb Haemost; 1988 Jun 16; 59(3):404-11. PubMed ID: 3142078
    [Abstract] [Full Text] [Related]

  • 4. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A, Ruusuvaara L.
    Thromb Haemost; 1988 Dec 22; 60(3):361-4. PubMed ID: 3149043
    [Abstract] [Full Text] [Related]

  • 5. Increase in plasma concentration of plasminogen activator inhibitor, fibrinogen, von Willebrand factor, factor VIII:C and in erythrocyte sedimentation rate with age.
    Aillaud MF, Pignol F, Alessi MC, Harle JR, Escande M, Mongin M, Juhan-Vague I.
    Thromb Haemost; 1986 Jun 30; 55(3):330-2. PubMed ID: 3092390
    [Abstract] [Full Text] [Related]

  • 6. Plasma fibrinolytic activity in patients undergoing major abdominal surgery.
    Mellbring G, Dahlgren S, Wiman B.
    Acta Chir Scand; 1985 Jun 30; 151(2):109-14. PubMed ID: 3873768
    [Abstract] [Full Text] [Related]

  • 7. Plasminogen activator inhibitor activity in bacterial infection.
    Páramo JA, Fernández Diaz FJ, Rocha E.
    Thromb Haemost; 1988 Jun 16; 59(3):451-4. PubMed ID: 3142082
    [Abstract] [Full Text] [Related]

  • 8. [Anti-activator inhibitors of plasminogen].
    Juhan-Vague I, Alessi MC, Aillaud MF.
    Ann Biol Clin (Paris); 1987 Jun 16; 45(2):202-6. PubMed ID: 3113299
    [Abstract] [Full Text] [Related]

  • 9. Postoperative changes in the plasmatic levels of tissue-type plasminogen activator and its fast-acting inhibitor--relationship to deep vein thrombosis and influence of prophylaxis.
    Páramo JA, Alfaro MJ, Rocha E.
    Thromb Haemost; 1985 Oct 30; 54(3):713-6. PubMed ID: 3937269
    [Abstract] [Full Text] [Related]

  • 10. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I, Valadier J, Alessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradimigni A, Collen D.
    Thromb Haemost; 1987 Feb 03; 57(1):67-72. PubMed ID: 3109059
    [Abstract] [Full Text] [Related]

  • 11. Daytime fluctuations in blood of tissue-type plasminogen activator (t-PA) and its fast-acting inhibitor (PAI-1).
    Kluft C, Jie AF, Rijken DC, Verheijen JH.
    Thromb Haemost; 1988 Apr 08; 59(2):329-32. PubMed ID: 3133814
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Impaired fibrinolysis in obstructive jaundice--evidence from clinical and experimental studies.
    Colucci M, Altomare DF, Chetta G, Triggiani R, Cavallo LG, Semeraro N.
    Thromb Haemost; 1988 Aug 30; 60(1):25-9. PubMed ID: 3142090
    [Abstract] [Full Text] [Related]

  • 14. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
    Verheijen JH, Rijken DC, Chang GT, Preston FE, Kluft C.
    Thromb Haemost; 1984 Jul 29; 51(3):396-7. PubMed ID: 6437007
    [Abstract] [Full Text] [Related]

  • 15. [Thromboembolic disease and anomalies of fibrinolysis].
    Juhan-Vague I, Aillaud MF, Valadier J, Alessi MC, Serradimigni A.
    Ann Med Interne (Paris); 1986 Jul 29; 137(6):471-4. PubMed ID: 3101564
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A sensitive assay, specific for endothelial cell type plasminogen activator inhibitor in blood plasma.
    Sprengers ED.
    Thromb Haemost; 1986 Feb 28; 55(1):74-7. PubMed ID: 3085268
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J, Turcu L, Wagner OF, Korninger C, Binder BR.
    J Lab Clin Med; 1987 Jun 28; 109(6):665-71. PubMed ID: 3108431
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Levels of fibrinolytic activators and inhibitors in plasma after severe trauma.
    Sørensen JV.
    Blood Coagul Fibrinolysis; 1994 Feb 28; 5(1):43-9. PubMed ID: 7514044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.